|Articles|June 1, 2003

Lending A Helping Hand

San Francisco - A randomized, two-center study conducted at the University of Cincinnati and Oregon Health & Science University suggests that topical bexarotene gel (Targretin) 1 percent monotherapy may be a promising new treatment for severe chronic hand dermatitis.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME